Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma

Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma

With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFL...

Full description

Saved in:
Bibliographic Details
Main Authors: Alqahtani, Saleh A., Chan, Wah Kheong, Yu, Ming-Lung
Format: Article
Published: W B SAUNDERS CO-ELSEVIER INC 2023
Subjects:
RC Internal medicine
Online Access:http://eprints.um.edu.my/38312/
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Malaya
id my.um.eprints.38312
record_format eprints
spelling my.um.eprints.383122024-06-12T01:25:58Z http://eprints.um.edu.my/38312/ Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma Alqahtani, Saleh A. Chan, Wah Kheong Yu, Ming-Lung RC Internal medicine With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFLD is more prevalent among individuals with obesity, an increasing prevalence among lean individuals has also been reported. W B SAUNDERS CO-ELSEVIER INC 2023-05 Article PeerReviewed Alqahtani, Saleh A. and Chan, Wah Kheong and Yu, Ming-Lung (2023) Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma. CLINICS IN LIVER DISEASE, 27 (2). pp. 211-223. DOI https://doi.org/10.1016/j.cld.2023.01.019 <https://doi.org/10.1016/j.cld.2023.01.019>. 10.1016/j.cld.2023.01.019
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic RC Internal medicine
spellingShingle RC Internal medicine
Alqahtani, Saleh A.
Chan, Wah Kheong
Yu, Ming-Lung
Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
description With the growing incidence of NAFLD on a global scale, management pathways and pharmacologic treatment options are eagerly awaited. Metabolic derangement in NAFLD associated with obesity is a key driver of disease progression and could be a useful target for pharmacologic intervention. Although NAFLD is more prevalent among individuals with obesity, an increasing prevalence among lean individuals has also been reported.
format Article
author Alqahtani, Saleh A.
Chan, Wah Kheong
Yu, Ming-Lung
author_facet Alqahtani, Saleh A.
Chan, Wah Kheong
Yu, Ming-Lung
author_sort Alqahtani, Saleh A.
title Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
title_short Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
title_full Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
title_fullStr Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
title_full_unstemmed Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
title_sort hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma
publisher W B SAUNDERS CO-ELSEVIER INC
publishDate 2023
url http://eprints.um.edu.my/38312/
_version_ 1805881104848125952

Similar Items